Levosimendan in outpatients with advanced heart failure: Single-center experience of 200 intermittent perfusions
Open Access
- 9 January 2023
- journal article
- research article
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 42 (4) , 335-343
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the CommunityJACC: Heart Failure, 2016
- Defining Advanced Heart Failure: A Systematic Review of Criteria Used in Clinical TrialsJournal of Cardiac Failure, 2016
- Medical Resource Use and Expenditure in Patients with Chronic Heart Failure: A Population-Based Analysis of 88 195 PatientsEuropean Journal of Heart Failure, 2016
- Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysisInternational Journal of Cardiology, 2016
- Levosimendan Improves Exercise Performance in Patients with Advanced Chronic Heart FailureESC Heart Failure, 2015
- Challenging the Two Concepts in Determining the Appropriate Pre-Discharge N-Terminal Pro-Brain Natriuretic Peptide Treatment Target in Acute Decompensated Heart Failure Patients: Absolute or Relative Discharge Levels?European Journal of Heart Failure, 2015
- Efficacy and Safety of the Pulsed Infusions of Levosimendan in Outpatients with Advanced Heart Failure (LevoRep) Study: A Multicentre Randomized TrialEuropean Journal of Heart Failure, 2014
- The Global Health and Economic Burden of Hospitalizations for Heart FailureJACC, 2014
- The annual global economic burden of heart failureInternational Journal of Cardiology, 2014
- A 6-Month Follow-up of Intermittent Levosimendan Administration Effect on Systolic Function, Specific Activity Questionnaire, and Arrhythmia in Advanced Heart FailureJournal of Cardiac Failure, 2007